Cetuximab As Second Line Therapy In Patients With Metastatic Esophageal Cancer - Phase II.
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2018
At a glance
- Drugs Cetuximab (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 30 Apr 2012 Actual patient number is 63 according to ClinicalTrials.gov.
- 30 Apr 2012 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 30 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.